Education
About Us
Working with TipRanks
Follow Us
Actinogen Medical Limited (ATGGF)
OTHER OTC:ATGGF
Total Valuation
Actinogen Medical Limited has a market cap or net worth of $63.36M. The enterprise value is $50.36M.
Market Cap$63.36M
Enterprise Value$50.36M
Share Statistics
Actinogen Medical Limited has 3.18B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3.18B
Owened by Insiders5.69%
Owened by Instutions
Financial Efficiency
Actinogen Medical Limited’s return on equity (ROE) is -0.66 and return on invested capital (ROIC) is -36.42%.
Return on Equity (ROE)-66.23%
Return on Assets (ROA)-61.21%
Return on Invested Capital (ROIC)-36.42%
Return on Capital Employed (ROCE)-64.34%
Revenue Per Employee―
Profits Per Employee―
Employee Count
Asset Turnover0.47
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Actinogen Medical Limited is -10.83. Actinogen Medical Limited’s PEG ratio is -2.06.
PE Ratio-10.83
PS Ratio14.23
PB Ratio7.18
Price to Fair Value7.18
Price to FCF-8.33
Price to Operating Cash Flow-8.34
PEG Ratio-2.06
Income Statement
In the last 12 months, Actinogen Medical Limited had revenue of $9.02M and earned -$9.66M in profits. Earnings per share was $0.00.
Revenue$9.02M
Gross Profit$9.02M
Operating Income-$9.56M
Pretax Income-$18.68M
Net Income-$9.66M
EBITDA-9.64M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -$8.72M and capital expenditures -$9.03K, giving a free cash flow of -$8.73M billion.
Operating Cash Flow-$8.72M
Free Cash Flow-$8.73M
Free Cash Flow per Share>-$0.01
Dividends & Yields
Actinogen Medical Limited pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-12.00%
Earnings Yield-9.23%
Stock Price Statistics
Beta0.04
52-Week Price Change100.00%
50-Day Moving Average0.02
200-Day Moving Average0.02
Relative Strength Index (RSI)48.16
Average Volume (3m)0.00
Important Dates
Actinogen Medical Limited upcoming earnings date is Aug 27, 2025, TBA.
Last Earnings DateFeb 24, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
Actinogen Medical Limited as a current ratio of 13.91, with Debt / Equity ratio of 0.02
Current Ratio13.91
Quick Ratio13.91
Debt to Market Cap0.00
Net Debt to EBITDA0.71
Interest Coverage Ratio-528.53
Taxes
In the past 12 months, Actinogen Medical Limited has paid -$9.02M in taxes.
Income Tax-$9.02M
Effective Tax Rate43.23%
Enterprise Valuation
Actinogen Medical Limited EV to EBITDA ratio is -10.23, with an EV/FCF ratio of -7.80.
EV to Sales13.31
EV to EBITDA-10.23
EV to Free Cash Flow-7.80
EV to Operating Cash Flow-7.80
Balance Sheet
Actinogen Medical Limited has $22.87M in cash and marketable securities with $289.64K in debt, giving a net cash position of -$22.58M billion.
Cash & Marketable Securities$22.87M
Total Debt$289.64K
Net Cash-$22.58M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 100.00%, with operating margin of -129.28%, and net profit margin of -131.34%.
Gross Margin100.00%
Operating Margin-129.28%
Pretax Margin-231.34%
Net Profit Margin-131.34%
EBITDA Margin-130.10%
EBIT Margin-133.47%
Analyst Forecast
The average price target for Actinogen Medical Limited is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast